The following article contains an excerpt from The Boston Globe’s coverage of the Garena virus.
By Chris Farrar/The Globe and Mail, October 19, 2017 The Globe and the Globe’s technology team are hard at work to help the people of the Boston region fight a new threat: viruses.
On Monday, the company posted a video to its YouTube channel showing a video of a man in a hospital bed, with a computer and a microphone strapped to his chest.
It begins with the man’s speech, which begins as a voiceover explaining how he was infected by a mysterious virus, which causes a variety of symptoms.
“My eyes were really hurting,” he says, explaining that he can’t sleep and can’t think clearly.
He says he’s got “a really hard time with everything.”
He explains he can get flu-like symptoms that are “pretty serious,” but he can also feel mild headaches.
The video then shows the man in his hospital bed talking to the camera and using a microphone to make his case for why he should get tested.
“I’m scared,” he begins.
“They said the virus could kill me.”
The video ends with the video of the man making a statement about his illness.
“This virus is real, it’s going to kill me,” the man says.
“The virus has to be stopped.”
The Globe’s tech team has been working on ways to fight the virus for weeks, and is using its expertise to try to help people who don’t have the tools to fight it.
But the company said it is now using a different kind of technology to help those people.
“We are using a technology called a virus scanner,” wrote the company’s founder, Jim Grewal.
“A virus scanner, when used correctly, can help identify the virus before it’s detected in the body.”
This technology, called a “scanner,” uses artificial intelligence to help analyze the virus’s symptoms, which can then be used to make predictions about the symptoms of those who might have contracted it.
Grewer said the scanner would be tested and used by the Globe in a limited capacity, and that its tests were designed to help fight the Gerena virus in a controlled environment.
Gerenas latest video is a small step forward, said Grewall.
“It’s still a small test, but we have to be careful not to overuse this technology,” he said.
“When we do overuse it, we will probably have to shut down.”
Grewals video, which was released on Monday, follows the viral outbreak that began late last week, and the first few cases of the virus have occurred in the Boston area.
The company has been testing its scanners on a small number of people, and it’s still testing its software and other hardware to determine whether it’s effective.
But Grewill said it’s not clear how effective it is yet.
“You can’t have a 100% success rate, even with a small amount of people,” he wrote in an email.
“As a company, we have a lot of work to do.
The people in Boston have done a lot to help.
The company’s technology is still being tested, but Grewll said he’s confident it’s ready to deploy in a lab. “
That said, we do believe that with the right testing and support, this is a step in the right direction.”
The company’s technology is still being tested, but Grewll said he’s confident it’s ready to deploy in a lab.
“If it’s good enough, we’ll get to it,” he writes.
Garenes technology also includes a tool called an RNAi machine, which Grewel said is designed to “make it really easy for the medical community to deploy this technology.”
Garens RNAi Machine, designed to scan the virus, is being tested on a large number of Boston residents.
(The Boston Globe) Garendas RNAi Machines have been used in clinical trials for years, but they have yet to be deployed for use in a real-world setting.
In Boston, Garents RNAi machines have been tested on hundreds of people who have contracted the virus in Boston.
“There is no shortage of patients in the region,” said Garen, who has also founded an organization called Boston Public Health for Health, which is working to test the machine in Boston and other areas of the country.
The virus, Grews RNAimation Machine, or BPC, has also been tested in several countries around the world.
It’s not yet available in Boston, but the company has started testing its technology on a handful of people.
But until then, Gerens goal is to have a working version of the machine available for use by the Boston Public health team.
“By testing it in Boston now, we can test it more broadly, and we can start working on other locations,” Grewa said. G